Literature DB >> 25387194

Erythropoietin for traumatic brain injury--reply.

Claudia S Robertson1, Jose-Miguel Yamal2, Barbara C Tilley2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25387194      PMCID： PMC4462129          DOI： 10.1001/jama.2014.12744

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Applying a phase II futility study design to therapeutic stroke trials.

Authors:  Yuko Y Palesch; Barbara C Tilley; David L Sackett; Karen C Johnston; Robert Woolson
Journal:  Stroke       Date:  2005-10-13       Impact factor: 7.914

2.  Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study.

Authors:  Peep Talving; Thomas Lustenberger; Leslie Kobayashi; Kenji Inaba; Galinos Barmparas; Beat Schnüriger; Lydia Lam; Linda S Chan; Demetrios Demetriades
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

3.  Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study.

Authors:  Peep Talving; Thomas Lustenberger; Kenji Inaba; Lydia Lam; Shahin Mohseni; Linda Chan; Demetrios Demetriades
Journal:  Arch Surg       Date:  2012-03

4.  Improved survival of critically ill trauma patients treated with recombinant human erythropoietin.

Authors:  Lena M Napolitano; Timothy C Fabian; Kathleen M Kelly; Jeffrey A Bailey; Ernest F Block; Wayne Langholff; Christopher Enny; Howard L Corwin
Journal:  J Trauma       Date:  2008-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.